Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
The commensal fungus Candida albicans causes oropharyngeal candidiasis (OPC; thrush) in settings of immunodeficiency. Although disseminated, vaginal, and oral candidiasis are all caused by C. albicans species, host defense against C. albicans varies by anatomical location. T helper 1 (Th1) cells have long been implicated in defense against candidiasis, whereas the role of Th17 cells remains controversial. IL-17 mediates inflammatory pathology in a gastric model of mucosal candidiasis, but is host protective in disseminated disease. Here, we directly compared Th1 and Th17 function in a model of OPC. Th17-deficient (IL-23p19(-/-)) and IL-17R-deficient (IL-17RA(-/-)) mice experienced severe OPC, whereas Th1-deficient (IL-12p35(-/-)) mice showed low fungal burdens and no overt disease. Neutrophil recruitment was impaired in IL-23p19(-/-) and IL-17RA(-/-), but not IL-12(-/-), mice, and TCR-alphabeta cells were more important than TCR-gammadelta cells. Surprisingly, mice deficient in the Th17 cytokine IL-22 were only mildly susceptible to OPC, indicating that IL-17 rather than IL-22 is vital in defense against oral candidiasis. Gene profiling of oral mucosal tissue showed strong induction of Th17 signature genes, including CXC chemokines and beta defensin-3. Saliva from Th17-deficient, but not Th1-deficient, mice exhibited reduced candidacidal activity. Thus, the Th17 lineage, acting largely through IL-17, confers the dominant response to oral candidiasis through neutrophils and antimicrobial factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-mediated immunity is central to mucocutaneous host defense against fungi such as C. albicans and Malassezia [10,99,100].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Host protection from oral Candida albicans infection is exquisitely reliant on IL-17 signaling, shown in both mouse and human settings”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Conti et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Although a few genes previously shown to be controlled by IL-17 were differentially expressed in the kidney during candidiasis, overall we saw a surprisingly distinct gene profile compared to analyses of IL-17-dependent genes in other settings (Fig 1B and S1A Fig) [18].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“we were intrigued by the surprisingly different gene profile seen in C. albicans-infected kidney compared to prior studies involving mucosal Candida infection such as the tongue [18].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [18]
In the citing paper
“At mucosal surfaces, IL-17 mediates antifungal activity by driving the expression of antimicrobial peptides and chemokines that facilitate neutrophil influx [18,19].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [18]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Odds, F. C. (1979) · Medical Entomology and Zoology · Cited by 1,297
Cited by
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Host protection from oral Candida albicans infection is exquisitely reliant on IL-17 signaling, shown in both mouse and human settings (Bär et al., 2012; Conti et al., 2016; Conti et al., 2009; Puel et al., 2011a).”
BackgroundSelf-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
“Il23a / and Il17ra / , but not Il12a / , mice are highly susceptible to oral candidiasis because of defective neutrophil recruitment and antimicrobial peptide production (Conti et al., 2009).”
BackgroundImmunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response
Hajishengallis, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.09.001 · Cited by 1,150
Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis
Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., Brown, J., Becker, C. A., Fleshner, P. R., Dubinsky, M., et al. (2012) · Science · doi:10.1126/science.1221789 · Cited by 1,073
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056
IL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800
The microbiome in infectious disease and inflammation
Honda, K., & Littman, D. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074937 · Cited by 791
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“IL-17 induces MCPIP1 mRNA (Zc3h12a) and protein in non-hematopoietic cells [74, 92, 93].”
BackgroundSelf-citationSaijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., Kusaka, T., Kubo, S., Chung, S.-H., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.001 · Cited by 733
“…681–691, May 28, 2010 ª2010 Elsevier Inc. Recently, it was reported that Th17 cells play an important role in the defense against C. albicans infection because IL-17RA-deficient mice and Th17 cell (IL-23p19)-deficient mice show increased susceptibility to mucosal candidiasis (Conti et al., 2009).”
BackgroundInfluentialPuel, A., Döffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachée-Chardin, M., Toulon, A., Bustamante, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091983 · Cited by 733
“In any case, proof that human IL-17 cytokines play an essential role in immunity to Candida will require the identification of mutations specifically impairing IL-17 immunity in other patients with inherited, isolated CMC without APS-I (Ryan et al., 2008; Hong et al., 2009).”
InfluentialThe mycobiota: interactions between commensal fungi and the host immune system
Underhill, D. M., & Iliev, I. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3684 · Cited by 695
The light and dark sides of intestinal intraepithelial lymphocytes
Cheroutre, H., Lambolez, F., & Mucida, D. (2011) · Nature Reviews Immunology · doi:10.1038/nri3007 · Cited by 693
“Finally, recent data have highlighted the intriguing phenomena of plasticity of CD4 + effector and regulatory T cell”
β‐glucan recognition by the innate immune system
Goodridge, H. S., Wolf, A. J., & Underhill, D. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00793.x · Cited by 688
“similarly observed that IL-17Rdeficient mice are highly susceptible to oropharyngeal Candida infection (91).”
BackgroundKisand, K., Bøe Wolff, A. S., Podkrajšek, K. T., Tserel, L., Link, M., Kisand, K. V., Ersvaer, E., Perheentupa, J., Erichsen, M. M., Bratanic, N., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091669 · Cited by 677
“In 304 Candidiasis and autoimmunity | Kisand et al. JEM VOL. 207, February 15, 2010 305 Br ief Definit ive Repor t Ma et al., 2008; Milner et al., 2008; Conti et al., 2009; Curtis and Way, 2009).”
BackgroundInfluentialSTAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A. J., Smits-van der Graaf, C. A. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 666
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“These include Salmonella enterica [72], Streptococcus pneumoniae [73], Listeria monocytogenes [25, 74],Staphylococcus aureus [16, 75], Helicobacter pylori [76], Citrobacter rondentium [16], herpes simplex virus [77],Trypanosoma cruzi [78, 79] and Candida albicans [15, 80].”
BackgroundRole of the Commensal Microbiota in Normal and Pathogenic Host Immune Responses
Littman, D. R., & Pamer, E. G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.004 · Cited by 556
“Candida albicans (Conti et al., 2009), induce Th17 cells in the intestine or at other mucosal surfaces.”
BackgroundOral Candidiasis: A Disease of Opportunity
Vila, T., Sultan, A. S., Montelongo-Jauregui, D., & Jabra-Rizk, M. A. (2020) · Journal of Fungi · doi:10.3390/jof6010015 · Cited by 537
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
“Consistently, IKK𝜀 deficiency also prevented the formation ofAct1-TRAF2-TRAF5 complex without disrupting interaction between TRAF6 and Act1, suggesting that phosphorylation of Act1 is necessary for the formation of the mRNA stabilization cascade.”
BackgroundRaffatellu, M., George, M. D., Akiyama, Y., Hornsby, M. J., Nuccio, S.-P., Paixao, T. A., Butler, B. P., Chu, H., Santos, R. L., Berger, T., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.011 · Cited by 525
“, 2008) and IL-17 (Conti et al., 2009; Raffatellu et al., 2008) during inflammation.”
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2022) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 477
“acting on IL-17R-expressing epithelial cells to induce the production of potent AMPs such as β-defensins and S100A8/A9 [165,168,195].”
BackgroundKhader, S. A., Gaffen, S. L., & Kolls, J. K. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.100 · Cited by 481
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
“As stated earlier, interleukin-17 is a key molecule in protection against extracellular bacteria and fungal pathogens (26, 115).”
BackgroundLin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., & Spellberg, B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000703 · Cited by 465
“albicans [40], respectively.”
Robinson, M. J., Osorio, F., Rosas, M., Freitas, R. P., Schweighoffer, E., Groß, O., Verbeek, J. S., Ruland, J., Tybulewicz, V., Brown, G. D., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082818 · Cited by 462
“In favor of that notion, a recent paper has shown that mice deficient in IL-23p19, a critical cytokine for Th17 responses, or in IL-17RA are very susceptible to oropharyngeal candidiasis (Conti et al., 2009).”
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“These findings indicate that Th17 cells, rather than TH1 cells, are necessary for neutrophil recruitment and defensin production.(113) Humans and animals lacking IL-17RA are more susceptible to oropharyngeal candidiasis (OPC), exhibit lower CXC chemokine levels, and show decreased recruitment of neutrophils to the ora…”
BackgroundKashem, S. W., Riedl, M. S., Yao, C., Honda, C. N., Vulchanova, L., & Kaplan, D. H. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.016 · Cited by 448
“In the oral mucosa, IL-17 from ab T cells, gd T cells, and ILCs has been reported to be required for resistance to C. albicans infec- tion (Conti et al., 2014, 2009; Gladiator et al., 2013; Gladiator and LeibundGut-Landmann, 2013).”
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
“TGF-b, while driving IL-17 production, potently inhibits IL22 in murine Th17 cells (7, 25).”
BackgroundInfluentialIgyártó, B. Z., Haley, K., Ortner, D., Bobr, A., Gerami-Nejad, M., Edelson, B. T., Zurawski, S. M., Malissen, B., Zurawski, G., Berman, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.005 · Cited by 435
“The mice infected with Candida albicans were sacrificed prior to infection and on day 2, 4, 5, and 7 after infection.”
BackgroundInfluentialQuorum sensing in fungi – a review
Albuquerque, P., & Casadevall, A. (2012) · Medical Mycology · doi:10.3109/13693786.2011.652201 · Cited by 431
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Okada, S., Markle, J. G., Deenick, E. K., Mele, F., Averbuch, D., Lagos, M., Alzahrani, M., Al-Muhsen, S., Halwani, R., Ma, C. S., et al. (2015) · Science · doi:10.1126/science.aaa4282 · Cited by 413
“Likewise, impaired IL-17A/F immunity was predicted to account for impaired protection against Candida albicans (35), as Rorc is the master gene controlling Th17 differentiation in inbred mice (11) and mutations affecting human IL17A/F immunity underlie isolated CMC (1, 26, 36).”
Tissue-Specific Immunity at the Oral Mucosal Barrier
Moutsopoulos, N. M., & Konkel, J. E. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.08.005 · Cited by 409
“Indeed, IL-17 secreting cells, both Th17 and TCRγδ T cells [17] [18], are implicated in protection against fungal infection.”
BackgroundIL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
Wolk, K., Witte, E., Witte, K., Warszawska, K., & Sabat, R. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0188-x · Cited by 395
“However, the role of IL-22 in the defense against oropharyngeal candidiasis, a common C. albicans infection in settings of immunodeficiency, is only minimal [ 85 ].”
BackgroundFungal dysbiosis: immunity and interactions at mucosal barriers
Iliev, I. D., & Leonardi, I. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.55 · Cited by 393
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannière, L., Rose, Y., de Suremain, M., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fdd832 · Cited by 394
“Mice with impaired IL-17 immunity are susceptible to Candida.12,31,38 It has been demonstrated that patients with IL-12RA1 deficiency display impaired development of IL-17producing T cells, although this impairment is less pronounced than that in STAT3-deficient patients.14 The high proportion of patients with candidi…”
BackgroundMyeloid C-type Lectin Receptors in Pathogen Recognition and Host Defense
Osorio, F., & Reis e Sousa, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.001 · Cited by 378
Immune responses to human fungal pathogens and therapeutic prospects
Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00826-w · Cited by 379
Gladiator, A., Wangler, N., Trautwein-Weidner, K., & LeibundGut-Landmann, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202924 · Cited by 382
“albicans sublingually as described (4) without immunosuppression.”
BackgroundInfluentialRole of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Th17 cells in immunity to Candida albicans
Hernández-Santos, N., & Gaffen, S. L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.008 · Cited by 361
“Although a failure to differentiate Th17 cells is the most obvious cause of their susceptibility to Candida, these patients also have impaired antifungal activity of saliva (Conti et al., 2011), and their keratinocytes show defective responses to Th17 cytokines (Minegishi et al., 2009).”
Self-citationInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Alcorn, J. F., Crowe, C. R., & Kolls, J. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135926 · Cited by 348
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Liu, J. Z., Jellbauer, S., Poe, A. J., Ton, V., Pesciaroli, M., Kehl-Fie, T. E., Restrepo, N. A., Hosking, M. P., Edwards, R. A., Battistoni, A., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.017 · Cited by 328
“The antimicrobial protein calprotectin, whose activity is dependent on zinc and manganese binding, is induced during bacterial and fungal infections in response to the cytokines IL-17 and IL-22 (Conti et al., 2009; Corbin et al., 2008; Kehl-Fie et al., 2011; Liang et al., 2006; Urban et al., 2009; Zheng et al., 2008).”
InfluentialCandida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
“In terms of adaptive immunity, T helper 1 (Th1) and T helper 17 (Th17) cells are the main T lymphocytes required for anti-Candida albicans responses (355, 356).”
BackgroundImportance of Candida–bacterial polymicrobial biofilms in disease
Harriott, M. M., & Noverr, M. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.07.004 · Cited by 313
“In particular, β-glucan signals via dectin-1 and TLR2 to promote Th17 cytokine production, which has been proposed to play a protective role against mucosal fungal infections [69-72].”
BackgroundInterleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
“Although not part of the IL-17 family based on sequence homology, IL-22 promotes immunity to OPC and gastric candidiasis (22, 40, 94).”
BackgroundInfluentialSelf-citationCX3CR1 + mononuclear phagocytes control immunity to intestinal fungi
Leonardi, I., Li, X., Semon, A., Li, D., Doron, I., Putzel, G., Bar, A., Prieto, D., Rescigno, M., McGovern, D. P. B., et al. (2018) · Science · doi:10.1126/science.aao1503 · Cited by 289
Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
Matijašić, M., Meštrović, T., Čipčić Paljetak, H., Perić, M., Barešić, A., & Verbanac, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082668 · Cited by 284
“Both IL-17 and IL-22 might act as inducers of antimicrobial peptides (AMPs) in epithelial cells and were reported as protective against mucosal fungal infections [67,68].”
BackgroundRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
The Cytokine IL-22 Promotes Pathogen Colonization by Suppressing Related Commensal Bacteria
Behnsen, J., Jellbauer, S., Wong, C. P., Edwards, R. A., George, M. D., Ouyang, W., & Raffatellu, M. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.003 · Cited by 282
“…(Aujla et al., 2008; Kinnebrew et al., 2010; Mastelic et al., 2012; Zheng et al., 2008), its induction was found to play no protective role in other infection models (Conti et al., 2009; Feinen and Russell, 2012; Graham et al., 2011; Kagami et al., 2010; Poulsen et al., 2013; Wilson et al., 2010).”
InfluentialIL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Pandiyan, P., Conti, H. R., Zheng, L., Peterson, A. C., Mathern, D. R., Hernández-Santos, N., Edgerton, M., Gaffen, S. L., & Lenardo, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.002 · Cited by 281
“albicans or PBS sham control (n = 11) as described previously (Conti et al., 2009).”
InfluentialTh17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
Siegel, A. M., Heimall, J., Freeman, A. F., Hsu, A. P., Brittain, E., Brenchley, J. M., Douek, D. C., Fahle, G. H., Cohen, J. I., Holland, S. M., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.016 · Cited by 278
“Mice lacking STAT3 within the CD4 T cell compartment demonstrate impaired antifungal and antibacterial responses, poor germinal center formation, and defects in antibody production (Conti et al., 2009; Eddahri et al., 2009; Nurieva et al., 2008).”
BackgroundCandida albicans interactions with epithelial cells and mucosal immunity
Naglik, J. R., Moyes, D. L., Wächtler, B., & Hube, B. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.06.009 · Cited by 277
“Th17 cells secrete IL-17A and IL-17F as well as IL-22 and have been associated with mucosal defense against oral candidiasis [91] but the exact role of these cells in anti-C.”
BackgroundChemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis
Hong, B.-Y., Sobue, T., Choquette, L., Dupuy, A. K., Thompson, A., Burleson, J. A., Salner, A. L., Schauer, P. K., Joshi, P., Fox, E., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0679-5 · Cited by 267
IL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.22 · Cited by 265
Interplay between Candida albicans and the mammalian innate host defense
Cheng, S.-C., Joosten, L. A. B., Kullberg, B.-J., & Netea, M. G. (2012) · Infection and Immunity · doi:10.1128/iai.06146-11 · Cited by 256
“Several studies, though not all, have shown that mice deficient in IL-17 or the IL-17 receptor are more susceptible to systemic (45) or mucosal (22) Candida infection.”
BackgroundSparber, F., De Gregorio, C., Steckholzer, S., Ferreira, F. M., Dolowschiak, T., Ruchti, F., Kirchner, F. R., Mertens, S., Prinz, I., Joller, N., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.002 · Cited by 255
“, 2017) and by experimental infections in mice (Conti et al., 2009; Gladiator et al., 2013).”
BackgroundOral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections
Conti, H. R., Peterson, A. C., Brane, L., Huppler, A. R., Hernández-Santos, N., Whibley, N., Garg, A. V., Simpson-Abelson, M. R., Gibson, G. A., Mamo, A. J., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130877 · Cited by 254
Self-citationRegulation of host-microbe interactions at oral mucosal barriers by type 17 immunity
Gaffen, S. L., & Moutsopoulos, N. M. (2020) · Science Immunology · doi:10.1126/sciimmunol.aau4594 · Cited by 252
Inflammation and gastrointestinal Candida colonization
Kumamoto, C. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.015 · Cited by 252
Th17 Cytokines and the Gut Mucosal Barrier
Blaschitz, C., & Raffatellu, M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9368-7 · Cited by 248
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Old and New Biological Therapies for Psoriasis
Rønholt, K., & Iversen, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112297 · Cited by 240
“Manageable mucocutaneous candida infection is associated with all the IL-17 inhibitors, which is probably due to the key role of IL-17 in the host defense against fungi [127,128].”
BackgroundIL-17 and IL-22: siblings, not twins
Eyerich, S., Eyerich, K., Cavani, A., & Schmidt-Weber, C. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.004 · Cited by 236
Precarious Balance: Th17 Cells in Host Defense
Peck, A., & Mellins, E. D. (2010) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236
“pergillus, among others, exacerbates pathology characterized by inadequate neutrophil recruitment, increased fungal burden, and reduced chemokine and antimicrobial expression (13, 35, 77, 95).”
BackgroundMicrobiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
Pandiyan, P., Bhaskaran, N., Zou, M., Schneider, E., Jayaraman, S., & Huehn, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00426 · Cited by 236
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
“role for this cytokine system in preventing infections to a long list of microbial pathogens, particularly those that act extracellularly such as gram-negative bacteria and the commensal yeast Candida albicans [46, 47 ].”
BackgroundWitte, E., Witte, K., Warszawska, K., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.08.002 · Cited by 233
“suffering from chronic mucocutaneous candidiasis in the context of autoimmune polyendocrine syndrome type I [137,138].”
BackgroundResultInfluentialCandidalysin: discovery and function in Candida albicans infections
Naglik, J. R., Gaffen, S. L., & Hube, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.06.002 · Cited by 229
Wüthrich, M., Gern, B., Hung, C. Y., Ersland, K., Rocco, N., Pick-Jacobs, J., Galles, K., Filutowicz, H., Warner, T., Evans, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43984 · Cited by 228
“Likewise, Th17 cell–deficient IL23p19–/– and Il17ra–/– mice exhibit severe oropharyngeal candidiasis, while Th1 cell–deficient Il12p35–/– mice show a low fungal burden and no overt disease (19).”
Dectin-1 and Dectin-2 in innate immunity against fungi
Saijo, S., & Iwakura, Y. (2011) · International Immunology · doi:10.1093/intimm/dxr046 · Cited by 226
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
Wüthrich, M., Deepe, G. S., & Klein, B. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074958 · Cited by 224
“In models of dermal and oral infection, IL-23deficient animals develop progressively worse disease (Conti et al. 2009; Kagami et al. 2010).”
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
The role of Syk/CARD9 coupled C-type lectins in antifungal immunity
Drummond, R. A., Saijo, S., Iwakura, Y., & Brown, G. D. (2011) · European Journal of Immunology · doi:10.1002/eji.201041252 · Cited by 221
Verma, A. H., Richardson, J. P., Zhou, C., Coleman, B. M., Moyes, D. L., Ho, J., Huppler, A. R., Ramani, K., McGeachy, M. J., Mufazalov, I. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8834 · Cited by 218
Kagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S., & Blauvelt, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001153 · Cited by 216
“In addition, another study using a mouse model of oral candidiasis demonstrated that mice deficient in Th17 cells developed more severe disease than Th1 cell-deficient mice (17).”
Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies
Doron, I., Leonardi, I., Li, X. V., Fiers, W. D., Semon, A., Bialt-DeCelie, M., Migaud, M., Gao, I. H., Lin, W.-Y., Kusakabe, T., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.016 · Cited by 210
“albicans has been implicated as a potent inducer of Th17 responses in humans and mice; it is bound by host antibodies and, thus, has the potential to induce protective immune responses or trigger inflammation in a context-dependent manner (Bacher et al., 2019; Conti et al., 2009; Huertas et al., 2017; Leonardi et al.,…”
Mouse model of oropharyngeal candidiasis
Solis, N. V., & Filler, S. G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.011 · Cited by 208
Adaptive immune responses to Candida albicans infection
Richardson, J. P., & Moyes, D. L. (2015) · Virulence · doi:10.1080/21505594.2015.1004977 · Cited by 204
“Mice unable to produce IL23 are highly susceptible to OPC,(46) while mice lacking IL-17 receptor-A (IL-17RA¡/-) or IL-23p19 (IL-23p19¡/-) have increased susceptibility to both OPC and systemic candidiasis.(36,47) Moreover, IL-17RC¡/- mice (deficient in the second IL17 receptor chain) are also susceptible to OPC.”
BackgroundCytokines IL-17 and IL-22 in the host response to infection
Valeri, M., & Raffatellu, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw111 · Cited by 202
“…bacterial invasion and enhancement of mucosal barrier repair and maintenance by stimulating epithelial cell proliferation and tight junction protein production (Ye et al. 2001a; Liang et al. 2006; Aujla et al. 2008; Raffatellu et al. 2008; Zheng et al. 2008; Conti et al. 2009; Pickert et al. 2009).”
BackgroundMucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200
Sherrington, S. L., Sorsby, E., Mahtey, N., Kumwenda, P., Lenardon, M. D., Brown, I., Ballou, E. R., MacCallum, D. M., & Hall, R. A. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006403 · Cited by 202
“Neutrophil depletion reduces inflammation and symptoms associated with VVC [42], suggesting that neutrophil recruitment in VVC is non-protective, in contrast to oral candidiasis where neutrophil recruitment and activation of Th17 responses are protective [43].”
BackgroundThe human gut mycobiome: pitfalls and potentials—a mycologist’s perspective
Suhr, M. J., & Hallen-Adams, H. E. (2015) · Mycologia · doi:10.3852/15-147 · Cited by 200
“…(1) Agirbasli et al. 2005, (2) Anderson 1917, (3) Angebault et al. 2013, (4) Biasoli et al. 2002, (5) Cano et al. 2014, (6) Chen et al. 2011, (7) Cohen et al. 1969, (8) David et al. 2014, (9) DiGiulio et al. 2008, (10) Dollive et al. 2012, (11) Finegold et al. 1974, (12) Finegold et al. 1977,…”
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 201
Metadata
- Authors
- Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., & Gaffen, S. L.
- Affiliations
- University at Buffalo, State University of New York (US)
- University of California, Los Angeles (US)
- Department of Oral Biology, School of Dental Medicine 1 ; 2 ; 3
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-02-09
- Volume
- 206
- Issue
- 2
- Pages
- 299-311
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2646568
- OpenAlex
- W2116516945
- Cited by
- 1,024
- References
- 77
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 45 · 2023: 38 · 2022: 47 · 2021: 61 · 2020: 56 · 2019: 59 · 2018: 59 · 2017: 60 · 2016: 61 · 2015: 70 · 2014: 74 · 2013: 63 · 2012: 67
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- National Institute of Dental and Craniofacial Research (DE010641, R01DE017088, R21DE018822, DE018822, DE007034, R01DE010641, T32DE007034, DE017088)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Th17 cells, IL-17 receptor signaling, oropharyngeal candidiasis, Candida albicans, Th1 cells, IL-23p19, IL-17RA, IL-12p35, neutrophil recruitment, TCR gamma delta T cells, IL-22, human beta-defensin 3, CXC chemokines, oral mucosa
- MeSH terms
- Interleukin-22, Acquired Immunodeficiency Syndrome, Animals, Candidiasis, Oral, Disease Susceptibility, Flow Cytometry, Humans, Interleukins, CD4-Positive T-Lymphocytes, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-17, Gene Expression Profiling, Mice, Interleukin-23 Subunit p19, Interleukin-12 Subunit p35
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.